共 50 条
- [21] Elotuzumab: no benefit for older patients with newly diagnosed multiple myeloma Comment LANCET HAEMATOLOGY, 2022, 9 (06): : E386 - E387
- [23] TOTAL THERAPY (TT) FOR NEWLY-DIAGNOSED MULTIPLE-MYELOMA (MM) BLOOD, 1993, 82 (10) : A198 - A198
- [26] Prevalence of pain and associations with functioning and quality of life in individuals newly-diagnosed with multiple sclerosis JOURNAL OF PAIN, 2016, 17 (04): : S18 - S19
- [29] Lenalidomide-Related Diarrhea Correlates with Disease Control in Newly-Diagnosed Patients with Multiple Myeloma CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E341 - E342
- [30] Undertreatment of Older Patients With Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (03): : 219 - 224